| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Neurodegeneration Research Group, John P. Robarts Research Institute (Drs. He and Strong, and C. Wilson); Psychological Services (Dr. Grace), London Health Sciences Centre; and the Departments of Clinical Neurological Sciences (Drs. Grace, Munoz, and Strong) and Pathology (Drs. Munoz and Strong), The University of Western Ontario, London, Ontario, Canada.
Address correspondence and reprint requests to Dr. Michael J. Strong, Room 7 OF 10, UC-LHSC, 339 Windermere Road, London, Ontario N6A 5A5, Canada; e-mail: mstrong{at}julian.uwo.ca
Background:— Traditionally considered a motor neuron–selective disorder, the clinical manifestations of ALS can include a frontotemporal dementia. Although the pathologic substrate of cognitive impairment remains to be defined, the presence of ubiquitin-immunoreactive (Ub+) intraneuronal inclusions in cortical regions has been suggested to constitute a pathologic marker of this process.
Methods:— The authors compared the neuropathological features of four cognitively impaired patients with ALS, four cognitively intact patients with ALS, and four neurologically normal patients. The extent and load of Ub+ neuronal inclusions, Ub+ dystrophic neurites, and superficial linear spongiosis (SLS) was determined among a number of cortical, hippocampal, and subcortical regions.
Results:— Although Ub+, alpha-synuclein-negative, and tau-negative neuronal inclusions were observed in both cognitively impaired and cognitively intact patients with ALS, their density and extent was greater among the former, with the difference greatest in the cingulate gyrus. Ub+ neurites were observed in a similar distribution. Only the presence of SLS, affecting the first and second cortical layers, reliably distinguished between the cognitively impaired and cognitively intact ALS subpopulations. In three of four cognitively impaired patients with ALS, SLS was associated with transcortical microglial activation, in the absence of detectable differences in astrocytosis, density of calbindin or parvalbumin neurons, or optical density of synaptophysin and SNAP-25.
Conclusions:— Although intraneuronal Ub+ inclusions and dystrophic neurites are observed in both ALS subpopulations, the presence of cognitive impairment was associated with a greater distribution and load of both neuropathologic features, suggesting a disease continuum. Moreover, cognitive impairment was uniformly associated with superficial linear spongiosis, a pathologic feature common to several forms of frontotemporal dementia.
This article has been cited by other articles:
|
|
 |
|
  S. Murphy, G. Gorman, C. Beetz, P. Byrne, M. Dytko, P. McMonagle, K. Kinsella SRN, M. Farrell, and M. Hutchinson Dementia in SPG4 hereditary spastic paraplegia: Clinical, genetic, and neuropathologic evidence Neurology, August 4, 2009; 73(5): 378 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Geser, N. J. Brandmeir, L. K. Kwong, M. Martinez-Lage, L. Elman, L. McCluskey, S. X. Xie, V. M.-Y. Lee, and J. Q. Trojanowski Evidence of Multisystem Disorder in Whole-Brain Map of Pathological TDP-43 in Amyotrophic Lateral Sclerosis Arch Neurol, May 1, 2008; 65(5): 636 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Wheaton, A. R. Salamone, D. M. Mosnik, R. O. McDonald, S. H. Appel, H. I. Schmolck, G. M. Ringholz, and P. E. Schulz Cognitive impairment in familial ALS Neurology, October 2, 2007; 69(14): 1411 - 1417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Irwin, C. F. Lippa, and J.M. Swearer Cognition and Amyotrophic Lateral Sclerosis (ALS) American Journal of Alzheimer's Disease and Other Dementias, September 1, 2007; 22(4): 300 - 312. [Abstract] [PDF]
|
|
|
|
 |
|
 D.M. Mezzapesa, A. Ceccarelli, F. Dicuonzo, A. Carella, M.F. De Caro, M. Lopez, V. Samarelli, P. Livrea, and I.L. Simone Whole-Brain and Regional Brain Atrophy in Amyotrophic Lateral Sclerosis AJNR Am. J. Neuroradiol., February 1, 2007; 28(2): 255 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Roos, O. Vesterberg, and M. Nordberg Metals in motor neuron diseases. Experimental Biology and Medicine, October 1, 2006; 231(9): 1481 - 1487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Strong, W. Yang, W. L. Strong, C. Leystra-Lantz, H. Jaffe, and H. C. Pant Tau protein hyperphosphorylation in sporadic ALS with cognitive impairment Neurology, June 13, 2006; 66(11): 1770 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Clark and M. S. Forman Frontotemporal lobar degeneration with motor neuron disease: a clinical and pathological spectrum. Arch Neurol, April 1, 2006; 63(4): 489 - 490. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Strong ALS--Not What We Thought. Arch Neurol, March 1, 2006; 63(3): 319 - 320. [Full Text] [PDF]
|
|
|
|
|
|
G. M. Ringholz, S. H. Appel, M. Bradshaw, N. A. Cooke, D. M. Mosnik, and P. E. Schulz Prevalence and patterns of cognitive impairment in sporadic ALS Neurology, August 23, 2005; 65(4): 586 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Paviour, A. J. Lees, K. A. Josephs, T. Ozawa, M. Ganguly, C. Strand, A. Godbolt, R. S. Howard, T. Revesz, and J. L. Holton Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy Brain, November 1, 2004; 127(11): 2441 - 2451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yang, M. M. Sopper, C. Leystra-Lantz, and M. J. Strong Microtubule-associated tau protein positive neuronal and glial inclusions in ALS Neurology, December 23, 2003; 61(12): 1766 - 1773. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
